Access to spacers and peak flow meters among medicaid patients with asthma.

Asthma morbidity and mortality have increased at alarming rates. Morbidity is significantly higher among minorities and low-income populations. The purpose of this study was to survey pharmacies licensed to provide both asthma medications and durable medical equipment (DME) to evaluate their acceptance of Medicaid as payment for spacers and peak flow meters in patients with Medicaid. Twenty-four pharmacies were identified and completed a telephone survey. Only 64% of the pharmacies licensed to accept Medicaid for DME provide this service. We postulate that improving DME licensing and claims reimbursement will impact medication compliance, as well as asthma morbidity and mortality.
AuthorsJames S Magee, Stacie M Jones, Mark E Ayers, William Golden, Perla A Vargas
JournalThe Journal of asthma : official journal of the Association for the Care of Asthma (J Asthma) Vol. 39 Issue 8 Pg. 687-91 (Dec 2002) ISSN: 0277-0903 [Print] United States
PMID12507188 (Publication Type: Comparative Study, Evaluation Studies, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Anti-Asthmatic Agents
  • Anti-Asthmatic Agents (therapeutic use)
  • Arkansas
  • Asthma (drug therapy, economics)
  • Durable Medical Equipment (economics)
  • Humans
  • Inhalation Spacers (economics)
  • Insurance, Pharmaceutical Services (economics)
  • Medicaid
  • Peak Expiratory Flow Rate (physiology)
  • Pharmacies (economics)
  • Reimbursement Mechanisms (economics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: